Rep. Lisa C. McClain Purchases Shares of Colgate-Palmolive Company (NYSE:CL)

Key Points

• Representative Lisa C. McClain purchased shares of Colgate-Palmolive stock valued between $1,001 and $15,000 on August 13th, according to a filing disclosed on September 12th.
• Colgate-Palmolive's stock is currently down 0.8%, trading at around $81.47, with a 52-week range of $81.41 to $105.37.
• The company recently announced a quarterly dividend of $0.52 per share, with a dividend yield of 2.6% and a payout ratio of 58.43%.

Representative Lisa C. McClain (R-Michigan) recently bought shares of Colgate-Palmolive Company NYSE: CL. In a filing disclosed on September 12th, the Representative disclosed that they had bought between $1,001 and $15,000 in Colgate-Palmolive stock on August 13th. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $50,001 - $100,000 in shares of Taiwan Semiconductor Manufacturing NYSE: TSM on 8/28/2025.
• Purchased $1,001 - $15,000 in shares of ACI Worldwide NASDAQ: ACIW on 8/19/2025.
• Purchased $1,001 - $15,000 in shares of HCA Healthcare NYSE: HCA on 8/19/2025.
• Sold $1,001 - $15,000 in shares of Amedisys NASDAQ: AMED on 8/18/2025.
• Purchased $1,001 - $15,000 in shares of Kite Realty Group Trust NYSE: KRG on 8/13/2025.
• Sold $1,001 - $15,000 in shares of ServiceNow NYSE: NOW on 8/13/2025.
• Purchased $1,001 - $15,000 in shares of JD.com NASDAQ: JD on 8/13/2025.
• Sold $1,001 - $15,000 in shares of Trade Desk NASDAQ: TTD on 8/13/2025.
• Sold $1,001 - $15,000 in shares of US Foods NYSE: USFD on 8/13/2025.
• Purchased $1,001 - $15,000 in shares of Agree Realty NYSE: ADC on 8/13/2025.

Colgate-Palmolive Stock Performance

Shares of CL stock traded down $0.30 during trading hours on Friday, reaching $81.23. The stock had a trading volume of 14,727,470 shares, compared to its average volume of 4,511,123. The firm has a 50-day simple moving average of $84.97 and a 200-day simple moving average of $89.22. The firm has a market capitalization of $65.65 billion, a PE ratio of 22.82, a price-to-earnings-growth ratio of 4.24 and a beta of 0.35. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. Colgate-Palmolive Company has a twelve month low of $81.01 and a twelve month high of $104.49.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its earnings results on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.89 by $0.03. The firm had revenue of $5.11 billion during the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. Colgate-Palmolive's revenue was up 1.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.91 EPS. As a group, equities analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be issued a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date of this dividend is Friday, October 17th. Colgate-Palmolive's dividend payout ratio (DPR) is 58.43%.

Analyst Ratings Changes

CL has been the subject of a number of recent analyst reports. Wells Fargo & Company decreased their target price on shares of Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating for the company in a research report on Monday, August 4th. Citigroup reduced their price objective on shares of Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating for the company in a research report on Monday, August 4th. UBS Group reduced their price objective on shares of Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating for the company in a research report on Thursday, July 17th. JPMorgan Chase & Co. reduced their price objective on shares of Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating for the company in a research report on Monday, August 4th. Finally, Barclays raised their price objective on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the company an "equal weight" rating in a research report on Tuesday, July 15th. Seven equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $98.00.

Institutional Trading of Colgate-Palmolive

A number of hedge funds have recently bought and sold shares of the company. Norges Bank purchased a new stake in shares of Colgate-Palmolive in the second quarter worth approximately $960,390,000. Price T Rowe Associates Inc. MD lifted its position in shares of Colgate-Palmolive by 18.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 34,009,078 shares of the company's stock worth $3,186,651,000 after purchasing an additional 5,269,140 shares in the last quarter. Schroder Investment Management Group lifted its position in shares of Colgate-Palmolive by 242.3% in the second quarter. Schroder Investment Management Group now owns 5,324,115 shares of the company's stock worth $483,962,000 after purchasing an additional 3,768,784 shares in the last quarter. Nuveen LLC purchased a new stake in shares of Colgate-Palmolive in the first quarter worth approximately $217,593,000. Finally, Goldman Sachs Group Inc. lifted its position in shares of Colgate-Palmolive by 34.5% in the first quarter. Goldman Sachs Group Inc. now owns 7,980,387 shares of the company's stock worth $747,762,000 after purchasing an additional 2,045,191 shares in the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election. Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.